TABLE 4.
Adjusted ORs comparing interventions to BA
| MI vs BA | RR vs BA | MI + RR vs BA | |||||||
|---|---|---|---|---|---|---|---|---|---|
| aORa | 95%CI | P value | aOR | 95% CI | P value | aOR | 95% CI | P value | |
| Primary outcome point, prevalence abstinence | |||||||||
| ITT MNAR | 1.56 | 0.81, 3.02 | 0.1847 | 3.17* | 1.69*, 5.94* | 0.0003* | 3.16* | 1.68*, 5.93* | 0.0003* |
| ITT MAR | 1.68 | 0.86, 3.27 | 0.1298 | 3.75* | 1.98*, 7.12* | <0.0001* | 3.55* | 1.87*, 6.75* | 0.0001* |
| Secondary outcome, prolonged abstinence | |||||||||
| ITT MNAR | 1.56 | 0.77, 3.13 | 0.2143 | 3.09* | 1.59*, 6.02* | 0.0009* | 2.89* | 1.48*, 5.63* | 0.0019* |
| ITT MAR | 1.63 | 0.79, 3.36 | 0.1889 | 3.46* | 1.76*, 6.83* | 0.0004* | 3.04* | 1.53*, 6.04* | 0.0016* |
Abbreviations: BA, brief advice (comparison); ITT MAR, intention to treat missing at random; ITT MNAR, intention to treat missing not at random; MI, motivational interviewing; RR, rate reduction; RR + MI, motivational interviewing + rate reduction.
aOR, adjusted for age, gender, race, ethnicity, education and baseline FTCD score.
Significant P values.